| Product Code: ETC9942978 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Drug Discovery Informatics Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Drug Discovery Informatics Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Drug Discovery Informatics Market - Industry Life Cycle |
3.4 United Kingdom (UK) Drug Discovery Informatics Market - Porter's Five Forces |
3.5 United Kingdom (UK) Drug Discovery Informatics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United Kingdom (UK) Drug Discovery Informatics Market Revenues & Volume Share, By Mode, 2021 & 2031F |
3.7 United Kingdom (UK) Drug Discovery Informatics Market Revenues & Volume Share, By Function, 2021 & 2031F |
3.8 United Kingdom (UK) Drug Discovery Informatics Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 United Kingdom (UK) Drug Discovery Informatics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for novel drug discovery solutions in the UK pharmaceutical industry |
4.2.2 Rising investment in research and development activities by pharmaceutical companies |
4.2.3 Technological advancements in informatics tools and software for drug discovery |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in the UK |
4.3.2 High costs associated with drug discovery informatics tools and software |
4.3.3 Limited availability of skilled professionals in the field of informatics in the UK |
5 United Kingdom (UK) Drug Discovery Informatics Market Trends |
6 United Kingdom (UK) Drug Discovery Informatics Market, By Types |
6.1 United Kingdom (UK) Drug Discovery Informatics Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Drug Discovery Informatics Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United Kingdom (UK) Drug Discovery Informatics Market Revenues & Volume, By Discovery Informatics, 2021- 2031F |
6.1.4 United Kingdom (UK) Drug Discovery Informatics Market Revenues & Volume, By Development Informatics, 2021- 2031F |
6.2 United Kingdom (UK) Drug Discovery Informatics Market, By Mode |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Drug Discovery Informatics Market Revenues & Volume, By In-house Informatics, 2021- 2031F |
6.2.3 United Kingdom (UK) Drug Discovery Informatics Market Revenues & Volume, By Outsourced Informatics, 2021- 2031F |
6.3 United Kingdom (UK) Drug Discovery Informatics Market, By Function |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Drug Discovery Informatics Market Revenues & Volume, By Sequencing and Target Data Analysis, 2021- 2031F |
6.3.3 United Kingdom (UK) Drug Discovery Informatics Market Revenues & Volume, By Docking, 2021- 2031F |
6.3.4 United Kingdom (UK) Drug Discovery Informatics Market Revenues & Volume, By Lead Generation Informatics, 2021- 2031F |
6.3.5 United Kingdom (UK) Drug Discovery Informatics Market Revenues & Volume, By Identification and Validation Informatics, 2021- 2031F |
6.3.6 United Kingdom (UK) Drug Discovery Informatics Market Revenues & Volume, By Molecular Modeling, 2021- 2031F |
6.3.7 United Kingdom (UK) Drug Discovery Informatics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Drug Discovery Informatics Market, By End-user |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Drug Discovery Informatics Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F |
6.4.3 United Kingdom (UK) Drug Discovery Informatics Market Revenues & Volume, By Contract Research Organizations, 2021- 2031F |
6.4.4 United Kingdom (UK) Drug Discovery Informatics Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Drug Discovery Informatics Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Drug Discovery Informatics Market Export to Major Countries |
7.2 United Kingdom (UK) Drug Discovery Informatics Market Imports from Major Countries |
8 United Kingdom (UK) Drug Discovery Informatics Market Key Performance Indicators |
8.1 Research and development expenditure in the UK pharmaceutical industry |
8.2 Number of partnerships and collaborations in drug discovery informatics sector |
8.3 Adoption rate of new informatics technologies in drug discovery processes in the UK |
9 United Kingdom (UK) Drug Discovery Informatics Market - Opportunity Assessment |
9.1 United Kingdom (UK) Drug Discovery Informatics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United Kingdom (UK) Drug Discovery Informatics Market Opportunity Assessment, By Mode, 2021 & 2031F |
9.3 United Kingdom (UK) Drug Discovery Informatics Market Opportunity Assessment, By Function, 2021 & 2031F |
9.4 United Kingdom (UK) Drug Discovery Informatics Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 United Kingdom (UK) Drug Discovery Informatics Market - Competitive Landscape |
10.1 United Kingdom (UK) Drug Discovery Informatics Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Drug Discovery Informatics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here